{"nct_id":"NCT03987295","title":"A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2019-09-27","start_date_type":"ACTUAL","primary_completion_date":"2024-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALEC"]}